Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 25, 2014

View Archived Issues

alpha-Amino-beta-lactam carbamates as systemic NAAA inhibitors

Researchers describe the function of MS susceptibility gene

New synthetic anti-TB drug from a rediscovered natural cyclic peptide

Newly identified genetic variations linked to riboflavin-responsive MADD disorder

Ajinomoto presents new MGAT2 inhibitors for obesity and dyslipidemia

Cynata licenses rights to Cellular Dynamics iPSC line for use with Cymerus technology

Merck & Co. presents results for MK-0674 in ovariectomized cynomolgus monkeys

Oxabact awarded E.U. orphan drug designation for short bowel syndrome

Viable mouse models of methylmalonic acidemia created

New agents for HCV infection disclosed by Idenix Pharmaceuticals

Allergan patents novel antibiotic conjugates for ocular disorders

Elusys Therapeutics completes phase III program for inhalational anthrax antibody

Convergence Pharmaceuticals achieves clinical proof of concept for CNV-1014802

Jiva Pharma synthesize new ascorbate esters of omega-3

TG Therapeutics exercises license option for TGR-1202

Merck KGaA to acquire Sigma-Aldrich

MedImmune's MEDI-3902 receives FDA fast track designation

Epirus reports 58-week follow-up data for infliximab biosimilar

Novavax reports data for H7N9 avian influenza VLP vaccine candidate

FDA approves Otezla for the oral treatment of plaque psoriasis

FDA awards fast track designation to aramchol for NASH

Gilead seeks Japanese approval for ledipasvir/sofosbuvir for genotype 1 HCV

Tekmira joins international consortium for clinical trials in Ebola

FibroGen reports 1-year data supporting the safety and efficacy profile of FG-3019

Endpoints met in phase III studies of secukinumab for psoriatic arthritis

Rexahn's RX-3117 awarded U.S. orphan drug designation for pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...